Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein

Publication files not online:

Author: Binnema, D.J. · Dooijewaard, G. · Turion, P.N.C.
Type:article
Date:1991
Institution: Gaubius Instituut TNO
Source:Thrombosis and Haemostasis, 2, 65, 144-148
Identifier: 231371
Keywords: Biology · Chemical Fractionation · Chromatography, Gel · Dextran Sulfate · Factor XII · Human · Plasminogen Activators · Prekallikrein · Serum Globulins · Support, Non-U.S. Gov't · Urinary Plasminogen Activator

Abstract

An analysis was made of the various possible activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction (DEF) of human plasma. scu-PA activators were detected in an assay system in which the substrate scu-PA, in physiological concentration (50 pM), was immuno-immobilized. After activation of the immobilized scu-PA for a certain period of time the activity of the generated amount of immuno-immobilized two-chain u-PA was determined with p1asminogen and the chromogenic substrate S-2251. The scu-PA activator activity (scuPA-AA) in the DEF of plasmas deficient in factor XII or prekallikrein was about half of that in the DEF of norma1 plasma. Separation of scuPA-AA in the DEF by gel chromatography showed to major peaks, one eluting with an apparent M(r1 of 500,000 and the other around M(r) 100,000. The former peak, which coincided with the activity peak of the kallikrein-kininogen complex, was absent in the DEF of plasma depleted of prekallikrein and therefore was identified as kallikrein. The latter peak was still present in the depleted p1asma and most likely represents plasmin, because its scu PA-AA coincided with the activity peak of plasmin and could be fully inhibited by antibodies raised against human plasminogen. It is concluded that plasmin and the contact-activation factor kallikrein each contribute for about 50% to the scuPA-AA in the DEF. Compared on a molar basis, however, plasmin was found to be almost 1,000 times more effective than kallikrein, and we conclude, therefore, that in vivo plasmin is the primary activator of scu-PA and the role of the contact system is of secondary importance.